PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHypercholesterolemia
MeSH D006937 - hypercholesterolemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006949:Hyperlipidemias
$
Success rate
D006937: 
Hypercholesterolemia
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MFenofibrate Duraprep  2006-09-29   
Fenofibrate, Chlorhexidine Soluprep 2029-07-26 2018-08-08   
AbbVieNiacin Niaspan Titration Starter Pack  1997-07-28   
Fenofibrate Tricor  1993-12-31 $606 M Q3/12-Q3/13 
Accord HealthcareAtorvastatin Atorvastatin  2018-03-30   
Ezetimibe Ezetimibe  2018-10-26   
Pravastatin Pravastatin  2016-11-17   
Rosuvastatin Rosuvastatin  2016-10-31   
Simvastatin Simvastatin  2008-02-26   
AgnitioAtorvastatin Atorvastatin  2021-09-02   
Ajanta PharmaFenofibrate Fenofibrate  2018-07-23   
Alembic PharmaceuticalsFenofibrate Fenofibrate  2019-08-09   
Alkem LaboratoriesAtorvastatin Atorvastatin  2018-12-21   
Colesevelam Colesevelam  2018-10-05   
Ezetimibe Ezetimibe  2017-12-21   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2017-12-22   
Rosuvastatin Rosuvastatin  2017-03-21   
AllerganClofibrate Clofibrate  1987-09-18   
Colesevelam Colesevelam  2020-09-02   
Ezetimibe Ezetimibe  2017-06-12   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2017-04-26   
Lovastatin Lovastatin  2001-12-17   
Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Mvc  1985-08-08   
Niacin Niacin  1982-01-01   
Pravastatin Pravastatin  2006-10-23   
Rosuvastatin Rosuvastatin  2016-04-29   
Simvastatin Simvastatin  2006-12-20   
Althera PharmaceuticalEzetimibe, Rosuvastatin Roszet 2033-05-01 2021-03-23   
AmgenEvolocumab Repatha  2015-08-27 $2,222 M Y2024 
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
65%
17/26
Phase 2
59%
26/44
Phase 3
68%
50/73
Approved: 30Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
3M
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use